Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0755
D

Failure to Ensure Timely Reordering and Availability of Controlled Antidiarrheal Medication

Swannanoa, North Carolina Survey Completed on 10-06-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to implement an effective system to ensure that an antidiarrheal medication, diphenoxylate-atropine (Lomotil), was reordered and available for administration, resulting in 12 missed doses for a resident with incontinence, end stage renal disease, and end stage renal dialysis. The resident was cognitively intact and had a physician's order for Lomotil to be administered four times daily for diarrhea. According to the Medication Administration Record, the medication was administered as ordered until it was put on hold due to being out of stock, and the resident missed doses over several days. Multiple staff members, including medication aides and nurses, became aware that the medication was out of stock, but there was confusion and miscommunication regarding the process for reordering a controlled medication. Some staff believed the medication had been reordered through the electronic Medication Administration Record (eMAR), but as a controlled substance, a new provider order was required, which was not immediately obtained. The pharmacy confirmed that a refill request was received but could not be processed without a new script, and there was no record of follow-up calls from the facility to the pharmacy. The Director of Nursing and other staff acknowledged that the process for reordering controlled medications was not clearly understood or followed. During the period when the medication was unavailable, the resident did not report significant changes in his condition and was not experiencing diarrhea according to staff and the resident himself. The Medical Director and Nurse Practitioner were eventually notified and placed the medication on hold until a new order could be obtained. The deficiency was attributed to a lack of an effective system for ensuring timely reordering and availability of controlled medications, as well as inadequate communication among staff regarding the specific requirements for ordering such medications.

An unhandled error has occurred. Reload 🗙